Sort
326,823 grants matching “clinical trial”
Head and Neck Cancer SPORE at the University of Wisconsin
$2,171,330Paul M Harari · University Of Wisconsin-Madison · P50 · FY2017 · DE
NICOTINE DEPENDENCE: RISK &RECOVERY OVER GENERATIONS
$2,171,310Miriam Hospital · P50 · FY2003 · CA
Upper Gastrointestinal Cancer Studies
$2,171,300Sanford M Dawsey · Division Of Cancer Epidemiology And Genetics · ZIA · FY2019 · CA
SPORE in Brain Cancer
$2,171,252Frederick F Lang · University Of Tx Md Anderson Can Ctr · P50 · FY2025 · CA
Discovering and Exploiting Mechanisms of Neuroblastoma Therapy Resistance
$2,171,238Robert C Seeger · Children'S Hospital Of Los Angeles · P01 · FY2018 · CA
The Alzheimer's Disease Research Center at the University of California, Irvine
$2,170,967Frank M Laferla · University Of California-Irvine · P50 · FY2016 · AG
Head and Neck Cancer SPORE at the University of Wisconsin
$2,170,679Paul M Harari · University Of Wisconsin-Madison · P50 · FY2016 · DE
Experimental Therapy for Brain Tumors
$2,170,371John H Sampson · Duke University · P01 · FY2018 · CA
PATHOGENESIS AND TREATMENT OF ACUTE HIV INFECTION
$2,170,255Massachusetts General Hospital · U01 · FY2003 · AI
SPORE in Soft Tissue Sarcoma
$2,170,212Samuel Singer · Sloan-Kettering Inst Can Research · P50 · FY2020 · CA
Noroviruses and Epidemic Gastroenteritis
$2,170,107Lisbeth Green · National Institute Of Allergy And Infectious Diseases · ZIA · FY2017 · AI
Imaging and Tissue Correlates to Optimize Management of Glioblastoma
$2,170,035Susan M Chang · University Of California, San Francisco · P01 · FY2016 · CA
1/2 Ganciclovir to Prevent Reactivation of Cytomegalovirus in Patients with Acute Respiratory Failure and Sepsis
$2,170,027Michael J Boeckh · Fred Hutchinson Cancer Center · UH3 · FY2024 · HL
RCMI Translational Research Network (RTRN)
$2,170,006Elizabeth O Ofili · Morehouse School Of Medicine · U54 · FY2017 · MD
VCU Massey Cancer Center Support Grant
$2,170,000Gordon D Ginder · Virginia Commonwealth University · P30 · FY2018 · CA
Colon Cancer Family Registry Cohort
$2,169,620Robert William Haile · Cedars-Sinai Medical Center · UM1 · FY2017 · CA
A comparative effectiveness trial of extended release naltrexone versus extended-release buprenorphine with individuals leaving jail
$2,169,367Michael Scott Gordon · Friends Research Institute, Inc. · UG1 · FY2022 · DA
Center for American Indian and Rural Health Equity
$2,169,112Alexandra K Adams · Montana State University - Bozeman · P20 · FY2019 · GM
Precision Medicine of Cancer
$2,168,979Curtis Harris · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Program Project in Models of Breast Cancer
$2,168,969Sloan-Kettering Institute For Cancer Res · P01 · FY2002 · CA
Prevention of AIDS
$2,168,641Barbara Felber · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
HIV Susceptibility and Pathogenesis in the Female Genital Tract
$2,168,559Alan L Landay · Rush University Medical Center · P01 · FY2012 · AI
Weill Cornell Medicine (WCM) SPORE in Prostate Cancer
$2,168,456Massimo F Loda · Weill Medical Coll Of Cornell Univ · P50 · FY2020 · CA
Immunoregulation /immune Recognition In Filarial/Nonfilarial Parasitic Infection
$2,168,414Thomas Nutman · National Institute Of Allergy And Infectious Diseases · ZIA · FY2009 · AI
Warfarin vs Aspirin in Reduced Ejection Fraction - STAT
$2,168,405John L Thompson · Columbia University Health Sciences · U01 · FY2008 · NS